The plan would need to be supported by the incoming Trump administration, which has vowed to cut costs across the federal government.
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
An estimated 7.4 million people would gain access to weight-loss drugs like Ozempic and Zepbound, which have out-of-pocket ...
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GL ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with ...
The Biden administration has proposed a new rule that would allow Medicare and Medicaid to cover popular weight-loss ...
The Biden administration is looking to extend Medicare and Medicaid coverage to include obesity drugs like Wegovy and Zepbound. Weight loss drugs are now excluded from mandatory coverage.
Biden administration's proposal to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid.